Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aromatase Inhibitors”

464 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 464 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Testing effectiveness (Phase 2)Study completedNCT01129622
What this trial is testing

Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)

Who this might be right for
Breast Cancer
Mount Sinai Hospital, Canada 16
Testing effectiveness (Phase 2)WithdrawnNCT03384095
What this trial is testing

Trial of Oral Hyaluronic Acid for the Prevention of Aromatase Inhibitor-Associated Arthralgias

Who this might be right for
Breast Neoplasm FemaleArthralgia
Erin Newton
Not applicableStudy completedNCT06307457
What this trial is testing

HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.

Who this might be right for
Breast Cancer
Pfizer 604
Early research (Phase 1)Study completedNCT01370551
What this trial is testing

Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients

Who this might be right for
Atrophic Vaginitis
Medinova AG 16
Large-scale testing (Phase 3)Study completedNCT00253422
What this trial is testing

Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 698
Testing effectiveness (Phase 2)Study completedNCT01603303
What this trial is testing

Preventing Sexual Dysfunction With Aromatase Inhibitors

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 187
Testing effectiveness (Phase 2)Ended earlyNCT00892268
What this trial is testing

Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint Pain

Who this might be right for
Breast CancerMenopausal SymptomsPain
University of Arizona 68
Not applicableStudy completedNCT00890058
What this trial is testing

A Case Control Study to Define Clinical, Immunologic and Radiographic Features of the Aromatase Inhibitor Arthralgia Syndrome

Who this might be right for
Arthralgia SyndromeArthritisSynovitis
Victoria Shanmugam 48
Not applicableStudy completedNCT01051609
What this trial is testing

Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients

Who this might be right for
Breast Cancer
Jonsson Comprehensive Cancer Center 27
Not applicableStudy completedNCT03665077
What this trial is testing

Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome

Who this might be right for
Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS)Breast Cancer
University of Arizona 28
Testing effectiveness (Phase 2)Study completedNCT00090857
What this trial is testing

Letrozole in Preventing Breast Cancer in Postmenopausal Women

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 49
Large-scale testing (Phase 3)Study completedNCT02511639
What this trial is testing

Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer Metastatic
Istituto Oncologico Veneto IRCCS 110
Not applicableStudy completedNCT03695341
What this trial is testing

500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AI

Who this might be right for
Breast Cancer
Fudan University 130
Not applicableStudy completedNCT01074320
What this trial is testing

Measuring Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors

Who this might be right for
Breast Cancer
HealthPartners Institute 150
Not applicableStudy completedNCT02804308
What this trial is testing

Combined Training on Body Composition of Postmenopausal Women Undergoing Treatment for Breast Cancer

Who this might be right for
Breast CancerAromatase InhibitorsPostmenopausal
Universidade Estadual Paulista Júlio de Mesquita Filho 83
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Testing effectiveness (Phase 2)Study completedNCT00012025
What this trial is testing

ICI 182780 in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 80
Not applicableUnknownNCT01793038
What this trial is testing

Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS Women

Who this might be right for
Polycystic Ovary SyndromeInfertility
Mansoura Integrated Fertility Center 160
Not applicableStudy completedNCT03069313
What this trial is testing

Vitamin B12 for Aromatase Inhibitors Musculoskeletal Symptoms

Who this might be right for
Relief of Joint Pain
Texas Tech University Health Sciences Center, El Paso 41
Next Page